Peter Finan has over 22 years of experience in pharmaceutical drug discovery, holding leadership roles at Novartis and other firms. He currently serves as Managing Partner at Epidarex Capital and sits on multiple biotech boards.
What Peter can write
Career
- Cancer Research UK
- Yamanouchi Research Institute
- Karus Therapeutics · Head of Biology
- Novartis · Executive Director of the Novartis Developmental and Molecular Pathways Platform
- Novartis Institute of BioMedical Research · Global Head of the Respiratory Disease Area and Site Head
- Epidarex Capital · Managing PartnerNow
Investments named in public bios
Focus
Education
Also at Epidarex Capital
Partners like Peter
At firms with a similar stage, sector and check size.
Alert me when Epidarex Capital is active
One email when Peter's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Peter Finan?
Peter Finan has over 22 years of experience in pharmaceutical drug discovery, holding leadership roles at Novartis and other firms. He currently serves as Managing Partner at Epidarex Capital and sits on multiple biotech boards.
How much does Peter Finan invest?
Epidarex Capital has not reported a check size. It invests at seed, series a.
How do I pitch Peter Finan?
Email [email protected], the firm's inbox for founders, and name Peter in the subject. A warm intro from a founder Epidarex Capital backed works better.
What did Peter Finan do before Epidarex Capital?
Cancer Research UK; Yamanouchi Research Institute; Head of Biology at Karus Therapeutics; Executive Director of the Novartis Developmental and Molecular Pathways Platform at Novartis; Global Head of the Respiratory Disease Area and Site Head at Novartis Institute of BioMedical Research.
Last updated 2026-10-15. Is this you? Ask for a correction.